Page 87 - Read Online
P. 87

Page 10 of 10                                         Erkan et al. Mini-invasive Surg 2018;2:30  I  http://dx.doi.org/10.20517/2574-1225.2018.51


                   A, Serkies K, Rogowska D, Tokar P; Polish Colorectal Study Group. Prediction of mesorectal nodal metastases after chemoradiation for
                   rectal cancer: results of a randomised trial: implication for subsequent local excision. Radiother Oncol 2005;76:234-40.
               36.  Yeo SG, Kim DY, Kim TH, Chang HJ, Oh JH, Park W, Choi DH, Nam H, Kim JS, Cho MJ, Kim JH, Park JH, Kang MK, Koom WS,
                   Kim JS, Nam TK, Chie EK, Kim JS, Lee KJ. Pathologic complete response of primary tumor following preoperative chemoradiother-
                   apy for locally advanced rectal cancer: long-term outcomes and prognostic significance of pathologic nodal status (KROG 09-01). Ann
                   Surg 2010;252:998-1004.
               37.  Shin YS, Yoon YS, Lim SB, Yu CS, Kim TW, Chang HM, Park JH, Ahn SD, Lee SW, Choi EK, Kim JC, Kim JH. Preoperative chemo-
                   radiotherapy followed by local excision in clinical T2N0 rectal cancer. Radiat Oncol J 2016;34:177-85.
               38.  Lezoche E, Guerrieri M, Paganini AM, Feliciotti F. Long-term results of patients with pT2 rectal cancer treated with radiotherapy and
                   transanal endoscopic microsurgical excision. World J Surg 2002;26:1170-4.
               39.  Garcia-Aguilar J, Renfro LA, Chow OS, Shi Q, Carrero XW, Lynn PB, Thomas CR Jr, Chan E, Cataldo PA, Marcet JE, Medich DS,
                   Johnson CS, Oommen SC, Wolff BG, Pigazzi A, McNevin SM, Pons RK, Bleday R. Organ preservation for clinical T2N0 distal rectal
                   cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institu-
                   tional, phase 2 trial. Lancet Oncol 2015;16:1537-46.
               40.  Dafnis G, Påhlman L, Raab Y, Gustafsson UM, Graf W. Transanal endoscopic microsurgery: clinical and functional results. Colorectal
                   Dis 2004;6:336-42.
               41.  Clermonts SHEM, van Loon YT, Wasowicz DK, Langenhoff BS, Zimmerman DDE. Comparative quality of life in patients following
                   transanal minimally invasive surgery and healthy control subjects. J Gastrointest Surg 2018;22:1089-97.
               42.  Verseveld M, Barendse RM, Gosselink MP, Verhoef C, de Graaf EJ, Doornebosch PG. Transanal minimally invasive surgery: impact on
                   quality of life and functional outcome. Surg Endosc 2016;30:1184-7.
               43.  Schiphorst AH, Langenhoff BS, Maring J, Pronk A, Zimmerman DD. Transanal minimally invasive surgery: initial experience and
                   short-term functional results. Dis Colon Rectum 2014;57:927-32.
               44.  Keller DS, Haas EM. Transanal minimally invasive surgery: state of the art. J Gastrointest Surg 2016;20:463-9.
               45.  Barendse RM, Dijkgraaf MG, Rolf UR, Bijnen AB, Consten EC, Hoff C, Dekker E, Fockens P, Bemelman WA, de Graaf EJ. Colorectal
                   surgeons’ learning curve of transanal endoscopic microsurgery. Surg Endosc 2013;27:3591-602.
               46.  Lee L, Kelly J, Nassif GJ, Keller D, Debeche-Adams TC, Mancuso PA, Monson JR, Albert MR, Atallah SB. Establishing the learning
                   curve of transanal minimally invasive surgery for local excision of rectal neoplasms. Surg Endosc 2018;32:1368-76.
   82   83   84   85   86   87   88   89   90   91   92